science

New Zealand’s insurance industry is failing to consistently meet the needs of Māori, with affordability barriers and difficulties insuring collectively owned land leaving them less likely to have cover, according to a study by the market watchdog.

New Zealand’s insurance industry is failing to consistently meet the needs of Māori, with affordability barriers and difficulties insuring collectively owned land leaving them less likely to have cover, according to a study by the market watchdog.

New Zealand’s insurance industry is failing to consistently meet the needs of Māori, with affordability barriers and difficulties insuring collectively owned land leaving them less likely to have cover, according to a study by the market watchdog.

An antitrust challenge by a group of state attorneys general has left Paramount CEO David Ellison hunting for avenues to get his deal for WBD done.

Biotech Breakout: What's in focus after Moderna's cancer win?

Capricor rises as FDA extends Deramiocel action date

Crinetics Pharmaceuticals stock hits all-time high at 84.8 USD

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters

FDA accepts United Therapeutics’ ralinepag application for PAH

Vanda gets EU orphan designation for psoriasis drug imsidolimab